Literature DB >> 15703818

Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers.

Mitsunori Ushigome1, Tsuneyuki Ubagai, Hirokazu Fukuda, Naoto Tsuchiya, Takashi Sugimura, Jun Takatsuka, Hitoshi Nakagama.   

Abstract

We have previously reported that the heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), a major hnRNP, binds to G-rich repetitive sequences and quadruplex (G4') structures in DNA, including the 5'-TTAGGG-3' telomere repeat and 5'-GGCAG-3' short-tandem-repeat. DNA synthesis arrest at the (GGG) sites within these repeats in vitro was retrieved by the addition of the hnRNP A1 protein or its N-terminal proteolytic product, UP1, in a dose-dependent manner. Therefore, functional perturbation of hnRNP A1 may abrogate the genomic stability of telomere repeats and other G-rich sequences, independent of its major role in transcriptional and translational regulation. In the present study, we conducted genetic and expression analysis of the hnRNP A1 gene in sporadic human colorectal cancers to clarify its possible involvement in human carcinogenesis. Of 30 lesions, one harbored a mutation at the -11 position from the translation initiation site, but none in the coding region. A single nucleotide polymorphism, an A or G-allele, was found in the 5' upstream promoter region of the gene. Quantitative gene expression analysis revealed that 60% (18/30) of cases showed over-expression of hnRNP A1 in cancer tissues by 2-fold or greater, compared to their normal colon tissues, with values of 78, 64 and 40% for clinicopathological stages II, III and IV, respectively. Although the biological consequences of hnRNP A1 overexpression in colorectal cancers remain to be clarified, it could contribute to maintenance of telomere repeats in cancer cells with enhanced cell proliferation. Alternatively, since the variations in the stoichiometry of hnRNP family proteins are considered to affect cell-specific gene expression, quantitative alteration of hnRNP A1 could result in facilitation of transformation of colon epithelial cells as a consequence of transcriptional and translational perturbation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703818

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  29 in total

1.  Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer.

Authors:  Zhen-Yu He; Hao Wen; Chuan-Bing Shi; Jie Wang
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

Review 3.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

4.  hnRNPA1 autoregulates its own mRNA expression to remain non-cytotoxic.

Authors:  Hiroaki Suzuki; Masaaki Matsuoka
Journal:  Mol Cell Biochem       Date:  2016-12-20       Impact factor: 3.396

Review 5.  The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.

Authors:  Asaf Shilo; Zahava Siegfried; Rotem Karni
Journal:  Mol Cell Oncol       Date:  2014-12-01

6.  Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.

Authors:  Huaqing Cui; Feng Wu; Yanling Sun; Guocai Fan; Qingming Wang
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

7.  hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration.

Authors:  Kim Moran-Jones; Joan Grindlay; Marc Jones; Ross Smith; Jim C Norman
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

8.  TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.

Authors:  Marion Flodrops; Gwendal Dujardin; Adeline Busson; Pascal Trouvé; Chandran Ka; Brigitte Simon; Danielle Arzur; Catherine Le Jossic-Corcos; Laurent Corcos
Journal:  Mol Biol Rep       Date:  2020-03-21       Impact factor: 2.316

9.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.

Authors:  Valerie Leduc; Louise Théroux; Doris Dea; Robert Dufour; Judes Poirier
Journal:  J Mol Neurosci       Date:  2015-11-05       Impact factor: 3.444

Review 10.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.